BioSpace News Archive

Business

BioSpace Movers & Shakers, Dec. 18

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

December 17, 2020
·
8 min read
·
Alex Keown
FDA

FDA Approvals: Therapies for Lupus, MS, Cancer and a Genomic Alteration in Pigs

The U.S. Food and Drug Administration (FDA) had several approvals this week. Read on to see what the regulatory agency gave the go-ahead to.

December 17, 2020
·
6 min read
·
Heather McKenzie
Business

Surface Oncology, GSK Enter $815 Million Agreement to Advance Immunotherapy Agent

Surface Oncology has agreed to grant exclusive worldwide licensing rights to GlaxoSmithKline for the development and commercialization of Surface Oncology’s SRF813, a fully human IgG1 antibody and immunotherapy designed to treat cancer.

December 17, 2020
·
3 min read
·
Brandon May
Drug Development

Four Potential Biotech Market Movers to Watch Going into 2021

As we eagerly look ahead to 2021, BioSpace spoke to four biotechs hoping to seize this opportunity in the first wave of COVID-19 vaccines and therapies – or make an impact in the second.

December 17, 2020
·
9 min read
·
Heather McKenzie
ENT Surgical Devices Market: Rising prevalence of ENT disorders is expected to drive the market

ENT surgical devices are mainly used for diagnosing, treating, or doing surgery related to disorders concerning ear, nose, and throat.

December 17, 2020
·
5 min read
Intravenous Pegloticase Market: Noteworthy increase in cases of gout cases in all worldwide locations is likely to boost sales opportunities in the market

Noteworthy increase in cases of gout cases in all worldwide locations is likely to boost sales opportunities in the global intravenous pegloticase market during the tenure of 2020 to 2030.

December 17, 2020
·
4 min read
Peramivir Drugs Market: Increase in prevalence of influenza is anticipated to drive the market

Peramivir is crystalline hygroscopic powder, soluble in deionized water, and it is synthesized in multiple step process using SM1, SM2, and SM3 as a starting material. Peramivir drugs are classified under the antiviral category.

December 17, 2020
·
4 min read
Calciphylaxis Treatment Market Growth and Restrain Factors Analysis Report

The rising prevalence of calcific uremic arteriolopathy in patients with renal failure, this can be important factor influencing demand for the global calciphylaxis treatment market.

December 17, 2020
·
3 min read
Ophthalmic Loupes Market | North America’s ophthalmic loupes market will observe promising growth by 2029

The ophthalmic loupes market is expected to gain immensely over the assessment period of 2019-2029.

December 17, 2020
·
3 min read
In-vitro Diagnostics Enzymes Market | Deep Study Analysis and Forecast by 2029

Rapid and accurate treatment and diagnosis of various clinical disorders are vital for best clinical outcome.

December 17, 2020
·
4 min read